HEADER TRANSFERASE 03-OCT-06 2IM2 TITLE CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH UTP AND MG2+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLIOVIRUS POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RNA-DIRECTED RNA POLYMERASE, RESIDUES 1748-2208; COMPND 5 EC: 2.7.7.48; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN POLIOVIRUS 1; SOURCE 3 ORGANISM_TAXID: 12081; SOURCE 4 STRAIN: MAHONEY; SOURCE 5 GENE: 3D; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PKKT7E KEYWDS NUCLEOTIDYLTRANSFERASE, POLIOVIRUS, 3D, RNA-DEPENDENT, POLYMERASE, KEYWDS 2 UTP, STABILIZATION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.A.THOMPSON,O.B.PEERSEN REVDAT 6 30-AUG-23 2IM2 1 REMARK REVDAT 5 20-OCT-21 2IM2 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 2IM2 1 VERSN REVDAT 3 24-FEB-09 2IM2 1 VERSN REVDAT 2 27-FEB-07 2IM2 1 JRNL REVDAT 1 12-DEC-06 2IM2 0 JRNL AUTH A.A.THOMPSON,R.A.ALBERTINI,O.B.PEERSEN JRNL TITL STABILIZATION OF POLIOVIRUS POLYMERASE BY NTP BINDING AND JRNL TITL 2 FINGERS-THUMB INTERACTIONS. JRNL REF J.MOL.BIOL. V. 366 1459 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17223130 JRNL DOI 10.1016/J.JMB.2006.11.070 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 84652 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 8256 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3707 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 226 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.11000 REMARK 3 B22 (A**2) : 6.11000 REMARK 3 B33 (A**2) : -12.22000 REMARK 3 B12 (A**2) : 7.69000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.55 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.61 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WAS REFINED WITH REMARK 3 ANOMALOUS DATA TO ACCOUNT FOR SIGNIFICANT ANOMALOUS SIGNAL FROM REMARK 3 ARSENIC, WHICH IS FOUND IN SEVERAL CAS RESIDUES IN THE REMARK 3 STRUCTURE. HOWEVER, THE DATA REDUCTION AND COMPLETENESS REMARK 3 STATISTICS ARE BASED ON MERGING ANOMALOUS REFLECTIONS. RESIDUES REMARK 3 132-135 HAVE POOR SIDECHAIN DENSITY AND THE MODEL REFLECTS THE REMARK 3 BACKBONE PATH IN THIS REGION OF THE STRUCTURE REMARK 4 REMARK 4 2IM2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-06. REMARK 100 THE DEPOSITION ID IS D_1000039736. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43793 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 7.150 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07700 REMARK 200 FOR THE DATA SET : 16.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.07 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43900 REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1RA6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 76.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, CACODYLATE, DTT, PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.42667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.71333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 56.57000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 18.85667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 94.28333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 52 158.08 179.20 REMARK 500 SER A 87 10.80 -69.37 REMARK 500 ASP A 129 -72.58 -55.55 REMARK 500 ARG A 136 43.97 73.68 REMARK 500 LYS A 139 -75.98 -26.70 REMARK 500 ILE A 150 -173.47 -60.35 REMARK 500 PRO A 153 157.17 -47.59 REMARK 500 LYS A 172 63.80 -65.10 REMARK 500 TYR A 237 -70.12 -42.17 REMARK 500 LYS A 276 -118.72 65.58 REMARK 500 ASP A 358 65.26 64.73 REMARK 500 LYS A 359 32.49 33.59 REMARK 500 LYS A 375 -0.23 67.58 REMARK 500 ASP A 406 108.92 -173.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A3001 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 LEU A 268 O REMARK 620 2 ASN A 269 O 82.9 REMARK 620 3 SER A 271 OG 80.8 97.0 REMARK 620 4 GLY A 284 O 142.8 81.7 134.6 REMARK 620 5 GLY A 285 O 79.4 123.5 131.5 81.4 REMARK 620 6 HOH A 669 O 109.1 159.1 69.1 96.8 76.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UTP A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 904 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RA7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH GTP AND REMARK 900 MG2+ REMARK 900 RELATED ID: 1RA6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APO POLIOVIRUS POLYMERASE REMARK 900 RELATED ID: 2ILY RELATED DB: PDB REMARK 900 STABILIZATION OF POLIOVIRUS POLYMERASE BY NTP BINDING AND FINGERS- REMARK 900 THUMB INTERACTIONS REMARK 900 RELATED ID: 2ILZ RELATED DB: PDB REMARK 900 STABILIZATION OF POLIOVIRUS POLYMERASE BY NTP BINDING AND FINGERS- REMARK 900 THUMB INTERACTIONS REMARK 900 RELATED ID: 2IM0 RELATED DB: PDB REMARK 900 STABILIZATION OF POLIOVIRUS POLYMERASE BY NTP BINDING AND FINGERS- REMARK 900 THUMB INTERACTIONS REMARK 900 RELATED ID: 2IM1 RELATED DB: PDB REMARK 900 STABILIZATION OF POLIOVIRUS POLYMERASE BY NTP BINDING AND FINGERS- REMARK 900 THUMB INTERACTIONS REMARK 900 RELATED ID: 2IM3 RELATED DB: PDB REMARK 900 STABILIZATION OF POLIOVIRUS POLYMERASE BY NTP BINDING AND FINGERS- REMARK 900 THUMB INTERACTIONS DBREF 2IM2 A 1 461 UNP P03300 POLG_POL1M 1748 2208 SEQADV 2IM2 CAS A 96 UNP P03300 CYS 1843 MODIFIED RESIDUE SEQADV 2IM2 CAS A 212 UNP P03300 CYS 1959 MODIFIED RESIDUE SEQADV 2IM2 CAS A 281 UNP P03300 CYS 2028 MODIFIED RESIDUE SEQADV 2IM2 CAS A 290 UNP P03300 CYS 2037 MODIFIED RESIDUE SEQADV 2IM2 ASP A 446 UNP P03300 LEU 2193 ENGINEERED MUTATION SEQADV 2IM2 ASP A 455 UNP P03300 ARG 2202 ENGINEERED MUTATION SEQRES 1 A 461 GLY GLU ILE GLN TRP MET ARG PRO SER LYS GLU VAL GLY SEQRES 2 A 461 TYR PRO ILE ILE ASN ALA PRO SER LYS THR LYS LEU GLU SEQRES 3 A 461 PRO SER ALA PHE HIS TYR VAL PHE GLU GLY VAL LYS GLU SEQRES 4 A 461 PRO ALA VAL LEU THR LYS ASN ASP PRO ARG LEU LYS THR SEQRES 5 A 461 ASP PHE GLU GLU ALA ILE PHE SER LYS TYR VAL GLY ASN SEQRES 6 A 461 LYS ILE THR GLU VAL ASP GLU TYR MET LYS GLU ALA VAL SEQRES 7 A 461 ASP HIS TYR ALA GLY GLN LEU MET SER LEU ASP ILE ASN SEQRES 8 A 461 THR GLU GLN MET CAS LEU GLU ASP ALA MET TYR GLY THR SEQRES 9 A 461 ASP GLY LEU GLU ALA LEU ASP LEU SER THR SER ALA GLY SEQRES 10 A 461 TYR PRO TYR VAL ALA MET GLY LYS LYS LYS ARG ASP ILE SEQRES 11 A 461 LEU ASN LYS GLN THR ARG ASP THR LYS GLU MET GLN LYS SEQRES 12 A 461 LEU LEU ASP THR TYR GLY ILE ASN LEU PRO LEU VAL THR SEQRES 13 A 461 TYR VAL LYS ASP GLU LEU ARG SER LYS THR LYS VAL GLU SEQRES 14 A 461 GLN GLY LYS SER ARG LEU ILE GLU ALA SER SER LEU ASN SEQRES 15 A 461 ASP SER VAL ALA MET ARG MET ALA PHE GLY ASN LEU TYR SEQRES 16 A 461 ALA ALA PHE HIS LYS ASN PRO GLY VAL ILE THR GLY SER SEQRES 17 A 461 ALA VAL GLY CAS ASP PRO ASP LEU PHE TRP SER LYS ILE SEQRES 18 A 461 PRO VAL LEU MET GLU GLU LYS LEU PHE ALA PHE ASP TYR SEQRES 19 A 461 THR GLY TYR ASP ALA SER LEU SER PRO ALA TRP PHE GLU SEQRES 20 A 461 ALA LEU LYS MET VAL LEU GLU LYS ILE GLY PHE GLY ASP SEQRES 21 A 461 ARG VAL ASP TYR ILE ASP TYR LEU ASN HIS SER HIS HIS SEQRES 22 A 461 LEU TYR LYS ASN LYS THR TYR CAS VAL LYS GLY GLY MET SEQRES 23 A 461 PRO SER GLY CAS SER GLY THR SER ILE PHE ASN SER MET SEQRES 24 A 461 ILE ASN ASN LEU ILE ILE ARG THR LEU LEU LEU LYS THR SEQRES 25 A 461 TYR LYS GLY ILE ASP LEU ASP HIS LEU LYS MET ILE ALA SEQRES 26 A 461 TYR GLY ASP ASP VAL ILE ALA SER TYR PRO HIS GLU VAL SEQRES 27 A 461 ASP ALA SER LEU LEU ALA GLN SER GLY LYS ASP TYR GLY SEQRES 28 A 461 LEU THR MET THR PRO ALA ASP LYS SER ALA THR PHE GLU SEQRES 29 A 461 THR VAL THR TRP GLU ASN VAL THR PHE LEU LYS ARG PHE SEQRES 30 A 461 PHE ARG ALA ASP GLU LYS TYR PRO PHE LEU ILE HIS PRO SEQRES 31 A 461 VAL MET PRO MET LYS GLU ILE HIS GLU SER ILE ARG TRP SEQRES 32 A 461 THR LYS ASP PRO ARG ASN THR GLN ASP HIS VAL ARG SER SEQRES 33 A 461 LEU CYS LEU LEU ALA TRP HIS ASN GLY GLU GLU GLU TYR SEQRES 34 A 461 ASN LYS PHE LEU ALA LYS ILE ARG SER VAL PRO ILE GLY SEQRES 35 A 461 ARG ALA LEU ASP LEU PRO GLU TYR SER THR LEU TYR ASP SEQRES 36 A 461 ARG TRP LEU ASP SER PHE MODRES 2IM2 CAS A 96 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 2IM2 CAS A 212 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 2IM2 CAS A 281 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 2IM2 CAS A 290 CYS S-(DIMETHYLARSENIC)CYSTEINE HET CAS A 96 9 HET CAS A 212 9 HET CAS A 281 9 HET CAS A 290 9 HET NA A3001 1 HET UTP A1001 29 HET ACY A 901 4 HET ACY A 902 4 HET ACY A 903 4 HET ACY A 904 4 HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETNAM NA SODIUM ION HETNAM UTP URIDINE 5'-TRIPHOSPHATE HETNAM ACY ACETIC ACID FORMUL 1 CAS 4(C5 H12 AS N O2 S) FORMUL 2 NA NA 1+ FORMUL 3 UTP C9 H15 N2 O15 P3 FORMUL 4 ACY 4(C2 H4 O2) FORMUL 8 HOH *226(H2 O) HELIX 1 1 ASP A 53 PHE A 59 1 7 HELIX 2 2 ASP A 71 SER A 87 1 17 HELIX 3 3 CAS A 96 GLY A 103 1 8 HELIX 4 4 PRO A 119 GLY A 124 1 6 HELIX 5 5 LYS A 126 LEU A 131 1 6 HELIX 6 6 ASP A 137 TYR A 148 1 12 HELIX 7 7 SER A 164 GLN A 170 1 7 HELIX 8 8 SER A 180 ASN A 201 1 22 HELIX 9 9 ASP A 213 TRP A 218 1 6 HELIX 10 10 LYS A 220 MET A 225 1 6 HELIX 11 11 GLY A 236 LEU A 241 1 6 HELIX 12 12 SER A 242 ILE A 256 1 15 HELIX 13 13 GLY A 257 ARG A 261 5 5 HELIX 14 14 VAL A 262 ASN A 269 1 8 HELIX 15 15 GLY A 292 TYR A 313 1 22 HELIX 16 16 ASP A 317 LEU A 321 5 5 HELIX 17 17 ASP A 339 TYR A 350 1 12 HELIX 18 18 PRO A 393 ARG A 402 1 10 HELIX 19 19 ASP A 406 ARG A 408 5 3 HELIX 20 20 ASN A 409 TRP A 422 1 14 HELIX 21 21 GLY A 425 ARG A 437 1 13 HELIX 22 22 VAL A 439 ALA A 444 1 6 HELIX 23 23 GLU A 449 PHE A 461 1 13 SHEET 1 A 5 GLU A 2 PRO A 8 0 SHEET 2 A 5 LYS A 278 LYS A 283 -1 O LYS A 283 N GLU A 2 SHEET 3 A 5 HIS A 270 TYR A 275 -1 N HIS A 273 O TYR A 280 SHEET 4 A 5 LEU A 154 VAL A 158 1 N THR A 156 O LEU A 274 SHEET 5 A 5 LEU A 175 ALA A 178 -1 O ILE A 176 N TYR A 157 SHEET 1 B 2 GLU A 26 PRO A 27 0 SHEET 2 B 2 TRP A 403 THR A 404 -1 O THR A 404 N GLU A 26 SHEET 1 C 2 GLU A 39 PRO A 40 0 SHEET 2 C 2 LEU A 162 ARG A 163 -1 O ARG A 163 N GLU A 39 SHEET 1 D 3 LYS A 228 PHE A 230 0 SHEET 2 D 3 ASP A 329 TYR A 334 -1 O TYR A 334 N LYS A 228 SHEET 3 D 3 LYS A 322 TYR A 326 -1 N TYR A 326 O ASP A 329 SHEET 1 E 2 PHE A 232 TYR A 234 0 SHEET 2 E 2 MET A 354 PRO A 356 -1 O THR A 355 N ASP A 233 SHEET 1 F 2 PHE A 377 ALA A 380 0 SHEET 2 F 2 ILE A 388 VAL A 391 -1 O HIS A 389 N ARG A 379 LINK C MET A 95 N CAS A 96 1555 1555 1.33 LINK C CAS A 96 N LEU A 97 1555 1555 1.33 LINK C GLY A 211 N CAS A 212 1555 1555 1.32 LINK C CAS A 212 N ASP A 213 1555 1555 1.33 LINK C TYR A 280 N CAS A 281 1555 1555 1.33 LINK C CAS A 281 N VAL A 282 1555 1555 1.33 LINK C GLY A 289 N CAS A 290 1555 1555 1.33 LINK C CAS A 290 N SER A 291 1555 1555 1.33 LINK O LEU A 268 NA NA A3001 1555 1555 2.49 LINK O ASN A 269 NA NA A3001 1555 1555 2.63 LINK OG SER A 271 NA NA A3001 1555 1555 2.85 LINK O GLY A 284 NA NA A3001 1555 1555 2.53 LINK O GLY A 285 NA NA A3001 1555 1555 2.39 LINK O HOH A 669 NA NA A3001 1555 1555 2.66 CISPEP 1 TYR A 118 PRO A 119 0 -0.06 SITE 1 AC1 6 LEU A 268 ASN A 269 SER A 271 GLY A 284 SITE 2 AC1 6 GLY A 285 HOH A 669 SITE 1 AC2 19 ARG A 163 LYS A 167 ARG A 174 LEU A 175 SITE 2 AC2 19 ILE A 176 TYR A 234 THR A 235 GLY A 236 SITE 3 AC2 19 TYR A 237 ASP A 238 SER A 288 HOH A 548 SITE 4 AC2 19 HOH A 606 HOH A 656 HOH A 672 HOH A 677 SITE 5 AC2 19 HOH A 678 HOH A 696 HOH A 726 SITE 1 AC3 6 ILE A 401 TRP A 403 THR A 404 THR A 410 SITE 2 AC3 6 HIS A 413 HOH A 633 SITE 1 AC4 2 ASP A 71 TYR A 350 SITE 1 AC5 2 LYS A 375 HOH A 686 SITE 1 AC6 5 TYR A 334 HIS A 336 PRO A 440 ARG A 443 SITE 2 AC6 5 HOH A 579 CRYST1 128.981 128.981 113.140 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007753 0.004476 0.000000 0.00000 SCALE2 0.000000 0.008952 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008839 0.00000